BackClearPoint Neuro Overview
ClearPoint Neuro Inc

ClearPoint Neuro Target Price

Analysts' average 12-month price target for ClearPoint Neuro is $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.96

Average Target Price

$21.0050.4% upside

3 analysts in the last 4 months

High: $25 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Lake Street$2579.1% upsideOpen
2026-08-04Stifel NicolausTom Stephan$2257.6% upsideOpen
2026-06-09Stifel NicolausTom Stephan$1614.6% upsideOpen
2025-01-21Lake StreetFrank Takkinen$30114.9% upsideOpen
2024-08-27Loop Capital MarketsFrank Takkinen$157.4% upsideOpen
2024-03-13Stifel NicolausMathew Blackman$935.5% downsideOpen

ClearPoint Neuro (CLPT) FAQ

As of the most recent data, CLPT shows a target price of $21. Scroll down for historical charts and peer comparison views.

If ClearPoint Neuro moved to the average analyst target of $21, shares would be roughly 50.4% higher than $13.96. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of ClearPoint Neuro's earnings trajectory.

Besides this target price page, Stockcircle has ClearPoint Neuro's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $21) with ownership activity and broader fundamentals.

ClearPoint Neuro's target price is $21; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.